Literature DB >> 9258188

The operative management of recurrent ureteropelvic junction obstruction.

D Rohrmann1, H M Snyder, J W Duckett, D A Canning, S A Zderic.   

Abstract

PURPOSE: Surgical repair of ureteropelvic junction obstruction is successful in 98% of cases. We evaluated children undergoing repeat pyeloplasty and discuss the etiology of recurrent ureteropelvic junction obstruction, surgical approach and outcome.
MATERIALS AND METHODS: Between 1982 and 1996, 366 children with ureteropelvic junction obstruction were surgically treated at our institution, including 16 who presented with recurrent ureteropelvic junction obstruction and required surgery.
RESULTS: Repeat repair was successful in all 16 patients, including ureterocalicostomy in 3 and dismembered pyeloplasty in the remainder. No nephrectomy was necessary. Anteriorly elongated flank incisions were made in all cases. Dense scar tissue around and obstructing the ureteropelvic junction was noted in the majority of cases. In 7 patients a redundant pelvis resulted in a kink at the ureteropelvic junction. A nephrostomy tube was placed in all cases and an additional transanastomotic stent was used in all but 2. Obstruction was relieved with 1 operation.
CONCLUSIONS: A redundant pelvis resulting in a kink at the ureteropelvic junction may contribute to a higher change of urinary leakage and subsequent obstructive scar formation in cases of failed pyeloplasty. Before repeat surgery anatomy should be precisely identified by antegrade and retrograde studies. The surgical approach usually involves identifying the ureter below the area of the previous surgery and then ensuring a tension-free anastomosis. If inadequate ureteral length or an intrarenal pelvis precludes direct anastomosis, ureterocalicostomy is an alternative. A nephrostomy tube and transanastomotic stent are advisable. Nephrectomy is rarely necessary and a good functional result can be anticipated.

Entities:  

Mesh:

Year:  1997        PMID: 9258188     DOI: 10.1097/00005392-199709000-00154

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Laparoscopic ureterocalicostomy for complicated upper urinary tract obstruction: mid-term follow-up.

Authors:  Marco Antonio Arap; Hiury Andrade; Fabio Cesar Miranda Torricelli; Francisco Tibor Denes; Anuar Ibrahim Mitre; Ricardo Jordão Duarte; Miguel Srougi
Journal:  Int Urol Nephrol       Date:  2013-11-12       Impact factor: 2.370

2.  Dismembered pyeloplasty using double 'J' stent in infants and children.

Authors:  George K Ninan; Chandrasen Sinha; Ramnik Patel; Rajendra Marri
Journal:  Pediatr Surg Int       Date:  2008-12-17       Impact factor: 1.827

3.  Laparoscopic management of recurrent ureteropelvic junction obstruction following pyeloplasty.

Authors:  George P Abraham; Avinash T Siddaiah; Krishnamohan Ramaswami; Datson George; Krishanu Das
Journal:  Urol Ann       Date:  2015 Apr-Jun

4.  Laparoscopic and robot-assisted ureterocalicostomy for treatment of primary and recurrent pelvi-ureteric junction obstruction in children: a multicenter comparative study with laparoscopic and robot-assisted Anderson-Hynes pyeloplasty.

Authors:  Ciro Esposito; Thomas Blanc; Dariusz Patkowski; Pedro José Lopez; Lorenzo Masieri; Anne-Francoise Spinoit; Maria Escolino
Journal:  Int Urol Nephrol       Date:  2022-07-21       Impact factor: 2.266

5.  Redo laparoscopic pyeloplasty for recurrent ureteropelvic junction obstruction: Propensity score matched analyses of a high-volume center.

Authors:  Jiayi Li; Yang Yang; Zonghan Li; Songqiao Fan; Xinyu Wang; Zhenzhen Yang; Pei Liu; Hongcheng Song; Weiping Zhang
Journal:  Front Pediatr       Date:  2022-09-08       Impact factor: 3.569

6.  Surgical approaches for treatment of ureteropelvic junction obstruction - a systematic review and network meta-analysis.

Authors:  Annemarie Uhlig; Johannes Uhlig; Lutz Trojan; Marc Hinterthaner; Alexander von Hammerstein-Equord; Arne Strauss
Journal:  BMC Urol       Date:  2019-11-11       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.